The latest strain of the COVID-19 virus, XEC, is circulating across the country. The new variant has been reported in at ...

Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer ...

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Shares in vaccine developer Vaxcyte soared by over 35% Tuesday after the company unveiled results from a large study testing its experimental pneumococcal shot that analysts described as a best-case ...

A new COVID variant is raising questions and capturing the attention of researchers heading into the fall and winter season.

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Health Canada authorized Moderna's updated COVID-19 vaccine on Tuesday to roll out in fall and winter immunization campaigns.

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians ...

The VDH reported on May 22 that a second juvenile in the "Under 10" age range has died of COVID-19 since the pandemic began ...

The therapeutic vaccine, codenamed mRNA-4359, is intended to boost people's immunity to a variety of advanced solid tumor ...